125 related articles for article (PubMed ID: 7672800)
1. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
[TBL] [Abstract][Full Text] [Related]
2. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
Goldfarb AN; Lewandowska K
Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
[TBL] [Abstract][Full Text] [Related]
4. Expression of TAL-1 proteins in human tissues.
Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
[TBL] [Abstract][Full Text] [Related]
5. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
6. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
7. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
[TBL] [Abstract][Full Text] [Related]
8. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of TAL-1 protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K; Mason D
J Pathol; 1996 Mar; 178(3):311-5. PubMed ID: 8778337
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
[TBL] [Abstract][Full Text] [Related]
11. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
Goldfarb AN; Greenberg JM
Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
[TBL] [Abstract][Full Text] [Related]
12. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
[TBL] [Abstract][Full Text] [Related]
13. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
14. A third tal-1 promoter is specifically used in human T cell leukemias.
Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
[TBL] [Abstract][Full Text] [Related]
16. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
Hsu HL; Cheng JT; Chen Q; Baer R
Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
[TBL] [Abstract][Full Text] [Related]
17. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
O'Neil J; Ventura JJ; Cusson N; Kelliher M
Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
[TBL] [Abstract][Full Text] [Related]
19. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia.
Aplan PD; Raimondi SC; Kirsch IR
J Exp Med; 1992 Nov; 176(5):1303-10. PubMed ID: 1402676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]